Nitroimidazole: Difference between revisions
m Protected "Nitroimidazole": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
[[Image:Metronidazole.png|left]] | [[Image:Metronidazole.png|left]] | ||
| Line 15: | Line 15: | ||
[[Category:Nitroimidazole antibiotics| ]] | [[Category:Nitroimidazole antibiotics| ]] | ||
[[Category:Aromatic compounds]] | [[Category:Aromatic compounds]] | ||
[[de:Nitroimidazole]] | [[de:Nitroimidazole]] | ||
[[fr:Nitroimidazole]] | [[fr:Nitroimidazole]] | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Latest revision as of 14:20, 20 August 2012
|
WikiDoc Resources for Nitroimidazole |
|
Articles |
|---|
|
Most recent articles on Nitroimidazole Most cited articles on Nitroimidazole |
|
Media |
|
Powerpoint slides on Nitroimidazole |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Nitroimidazole at Clinical Trials.gov Trial results on Nitroimidazole Clinical Trials on Nitroimidazole at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Nitroimidazole NICE Guidance on Nitroimidazole
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Nitroimidazole Discussion groups on Nitroimidazole Patient Handouts on Nitroimidazole Directions to Hospitals Treating Nitroimidazole Risk calculators and risk factors for Nitroimidazole
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Nitroimidazole |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Nitroimidazoles are imidazole heterocycles with a nitro group that have been used to combat anaerobic bacterial and parasitic infections. Perhaps the most common example is metronidazole (Flagyl ®). Other heterocycles such as nitrothiazoles (thiazole) are also used for this purpose. Nitroheterocycles may be reductively activated in hypoxic cells, and then undergo redox recycling or decompose to toxic products.
References
- Annu. Rev. Pharmacol. Toxicol. 1989. 29:165~7